Artemis Therapeutics AI jobs and careers

About Artemis Therapeutics AI

Artemis Therapeutics is an artificial intelligence–driven biopharmaceutical company focused on accelerating the discovery and development of next-generation therapeutics. By combining advanced machine learning, molecular modeling, and biological validation, Artemis is transforming the traditional drug discovery process, which can often take more than a decade and cost billions of dollars. The company was founded by Dr. Artem Cherkasov and Dr. Mads Daugaard to harness more than 30 years of research in computational chemistry, molecular modeling, and precision drug discovery. Artemis’s proprietary AI platform integrates advanced algorithms with high-performance computing to rapidly screen billions—and soon trillions—of potential drug candidates against disease targets, dramatically increasing the speed and efficiency of identifying promising therapeutics. At the core of the platform is DeepDocking™, the world’s first deep learning–accelerated virtual screening technology, capable of dramatically expanding the scale of computational drug discovery. Artemis continues to advance this technology through next-generation systems such as DeepDocking-Lightning™ and DeepDocking-Ultra™, enabling unprecedented speed and scale in structure-based drug discovery. Artemis operates as an asset-driven biopharma company, focusing on discovering and advancing proprietary drug candidates rather than providing AI services alone. Six drug candidates identified using the platform have already been licensed to pharmaceutical companies, demonstrating the platform’s ability to generate high-value therapeutic assets. With a world-class team of scientists, industry leaders, and advisors, Artemis Therapeutics is working to unlock new possibilities in precision medicine and accelerate the delivery of safer, more effective therapies to patients worldwide.